IDENTIFICATION OF RESISTANCE ASSOCIATED CPG METHYLATION CHANGES IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING INDUCTION CHEMOTHERAPY

被引：0
|
作者：
Niederwieser, C. [1 ]
Rohde, C. [1 ]
Serve, H. [2 ]
Berdel, W. [3 ]
Ehninger, G. [4 ]
Goellner, S. [1 ]
Mueller, L. [1 ]
Mueller-Tidow, C. [1 ]
机构：
[1] Univ Hosp Halle, Dept Internal Med Hematol & Oncol 4, Halle, Germany
[2] Univ Klinikum Frankfurt, Med Klin 2, Frankfurt, Germany
[3] Univ Klinikum Munster, Med Klin A, Munster, Germany
[4] Tech Univ Dresden, Univ Klinikum, Med Klin & Poliklin 1, Dresden, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E927
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [21] Clinical Infections and Bloodstream Isolates Associated with Fever in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
    T.A. Madani
    Infection, 2000, 28 : 367 - 374
  • [22] Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia
    Arain, Saad
    Shah, Eshana
    Yavuz, Betul Gok
    Stettner, Sarah
    Calip, Gregory Sampang
    Khan, Irum
    Patel, Pritesh
    Quigley, John G.
    BLOOD, 2020, 136
  • [23] A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy
    Alibhai, S. M. H.
    Durbano, S.
    Breunis, H.
    Brandwein, J. M.
    Timilshina, N.
    Tomlinson, G. A.
    Oh, P. I.
    Cubs-Reed, S. N.
    LEUKEMIA RESEARCH, 2015, 39 (11) : 1178 - 1186
  • [24] Endurance and resistance training in patients with acute leukemia undergoing induction chemotherapy—a randomized pilot study
    Anja Wehrle
    Sarah Kneis
    Hans-Hermann Dickhuth
    Albert Gollhofer
    Hartmut Bertz
    Supportive Care in Cancer, 2019, 27 : 1071 - 1079
  • [25] Identification of Somatic Mutation Contributing to Chemotherapy Resistance in Acute Myeloid Leukemia
    Honda, Akira
    Koya, Junji
    Yoshimi, Akihide
    Kataoka, Keisuke
    Arai, Shunya
    Kurokawa, Mineo
    BLOOD, 2016, 128 (22)
  • [26] Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy
    Delavigne, Karen
    Berard, Emilie
    Bertoli, Sarah
    Corre, Jill
    Duchayne, Eliane
    Demur, Cecile
    Mansat-De Mas, Veronique
    Borel, Cecile
    Picard, Muriel
    Alvarez, Muriel
    Sarry, Audrey
    Huguet, Francoise
    Recher, Christian
    HAEMATOLOGICA, 2014, 99 (03) : 474 - 480
  • [27] Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit
    Ahmed, Tamjeed
    Koch, Abby L.
    Isom, Scott
    Klepin, Heidi D.
    Bishop, Jonathan M.
    Ellis, Leslie R.
    Berenzon, Dmitriy
    Howard, Dianna
    Lyerly, Susan
    Powell, Bayard L.
    Pardee, Timothy S.
    LEUKEMIA RESEARCH, 2017, 62 : 51 - 55
  • [28] Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia
    Song, Kui
    Li, Min
    Xu, Xiaojun
    Xuan, Li
    Huang, Guinian
    Liu, Qifa
    ONCOLOGY LETTERS, 2016, 12 (01) : 334 - 342
  • [29] Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
    Kroeger, Heike
    Jelinek, Jaroslav
    Estecio, Marcos R. H.
    He, Rong
    Kondo, Kimie
    Chung, Woonbok
    Zhang, Li
    Shen, Lanlan
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Issa, Jean-Pierre J.
    BLOOD, 2008, 112 (04) : 1366 - 1373
  • [30] Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients
    Peric, Kaylene M.
    Reeves, David J.
    LEUKEMIA RESEARCH, 2015, 39 (02) : 173 - 176
12345